Skip to main content

Table 2 Clinical and biochemical parameters at the start of combined therapy with PD and HD

From: Clinical efficacy of combined therapy with peritoneal dialysis and hemodialysis

Author, year SBP [mmHg] DBP [mmHg] Urine volume [mL/day] UF volume [mL/day] BUN [mg/dL] Cr [mg/dL] β2m [mg/L] D/P Cr Weekly Kt/V Weekly Ccr [L/week/1.73 m2]
Hashimoto, 2000 [9]          1.98 ± 0.28 58.6 ± 10.5
Agarwal, 2003 [12]          1.96 ± 0.51  
Kawanishi, 2006 [14] 152 ± 25   151 ± 25 794 ± 447 63.0 ± 18.2 13.1 ± 3.3 35.8 ± 14.3   1.86 ± 0.52  
Hoshi, 2006 [15] 141 ± 5 72 ± 4    76.4 ± 7.8 13.5 ± 0.8     
Kawanishi, 2007 [16]        33.3 ± 11.3   1.55 ± 0.4 42.0 ± 7.7
Matsuo, 2010 [18] 145 ± 22 84 ± 17 253 ± 405 907 ± 579 61 ± 16 13.5 ± 3.6 35.9 ± 7.5 0.65 ± 0.11   50.2 ± 5.3
Tanaka, 2011 [19] 156 ± 17   200 (0–900)    12.2 ± 2.8    2.2 ± 0.4  
Maruyama, 2014 [21] 144 ± 22 80 ± 14 150 (0–2000) 1000 (−500–2350) 59.2 ± 14.6 12.9 ± 3.4 34.4 ± 7.2 0.67 ± 0.11 1.8 ± 0.4 49.9 ± 13.1
  1. PD peritoneal dialysis, HD hemodialysis, SBP systolic blood pressure, DBP diastolic blood pressure, UF ultrafiltration, BUN blood urea nitrogen, Cr creatinine, β2m β2 microglobulin, D/P Cr dialysate-to-plasma ratio of creatinine, Ccr creatinine clearance